化合物 Quizartinib HCl T71400

Product Introduction
Bioactivity


英文名: Quizartinib HCl

描述: Quizartinib, also know as AC220 and AC010220, is an orally available FLT3 / STK1 inhibitor with potential antineoplastic activity. Class III receptor tyrosine kinase inhibitor AC220 selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs), resulting in inhibition of ligand-independent leukemic cell proliferation and apoptosis. Mutations in FLT3, resulting in constitutive activation, are the most frequent genetic alterations in acute myeloid leukemia (AML) and occur in approximately one-third of AML cases.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: Quizartinib HCl | Nicorandil d4

化合物 Quizartinib HCl T71400信息由TargetMol中国为您提供，如您想了解更多关于化合物 Quizartinib HCl T71400报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途